The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-cyclopropyl-3-fluoro-5-(3-(2-hydroxypropan-2-yl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl)-4-methylbenzamide ID: ALA2087526
PubChem CID: 25060876
Max Phase: Preclinical
Molecular Formula: C20H21FN4O2
Molecular Weight: 368.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccn2c(C(C)(C)O)nnc2c1
Standard InChI: InChI=1S/C20H21FN4O2/c1-11-15(8-13(9-16(11)21)18(26)22-14-4-5-14)12-6-7-25-17(10-12)23-24-19(25)20(2,3)27/h6-10,14,27H,4-5H2,1-3H3,(H,22,26)
Standard InChI Key: VASDBJLAJXMNPY-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
2.7611 -7.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7599 -8.4773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4747 -8.8902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1912 -8.4769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1883 -7.6463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4729 -7.2372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9012 -7.2311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6172 -7.6409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8981 -6.4061 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3302 -7.2258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1541 -7.2264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7389 -6.5135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0451 -8.8893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4745 -9.7152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7547 -10.1236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1815 -10.9504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1853 -10.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4651 -11.3615 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7555 -10.9456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1406 -11.4919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4702 -12.2456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2883 -12.1651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7216 -12.8618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0465 -7.2376 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.3327 -13.5894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5461 -12.8348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1292 -13.5708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 13 1 0
1 2 2 0
3 14 1 0
14 15 2 0
5 7 1 0
3 4 2 0
7 8 1 0
14 17 1 0
15 19 1 0
18 16 1 0
16 17 2 0
18 19 1 0
7 9 2 0
4 5 1 0
8 10 1 0
11 10 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 18 1 0
12 11 1 0
22 23 1 0
10 12 1 0
1 24 1 0
2 3 1 0
23 25 1 0
5 6 2 0
23 26 1 0
6 1 1 0
23 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.41Molecular Weight (Monoisotopic): 368.1649AlogP: 2.96#Rotatable Bonds: 4Polar Surface Area: 79.52Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.53CX Basic pKa: 1.24CX LogP: 1.95CX LogD: 1.95Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.74Np Likeness Score: -1.18
References 1. Aiguadé J, Balagué C, Carranco I, Caturla F, Domínguez M, Eastwood P, Esteve C, González J, Lumeras W, Orellana A, Preciado S, Roca R, Vidal L, Vidal B.. (2012) Novel triazolopyridylbenzamides as potent and selective p38α inhibitors., 22 (10): [PMID:22521646 ] [10.1016/j.bmcl.2012.03.099 ]